Peter Olson

Peter Olson serves as the Chief Scientific Officer at Iambic Therapeutics, bringing extensive experience in the pharmaceutical and biotechnology sectors. Previously, Peter Olson held the position of Vice President of Research at Bristol Myers Squibb, where significant contributions were made to advancing research initiatives. Early in Peter Olson's career, a postdoctoral fellowship was completed at UCSF, further solidifying a strong foundation in scientific inquiry and research expertise.